Open access
Open access
Powered by Google Translator Translator

Infectious Diseases (all articles)

WHO approval of Chinese CoronaVac COVID vaccine will be crucial to curbing pandemic.

6 Jun, 2021 | 23:56h | UTC

WHO approval of Chinese CoronaVac COVID vaccine will be crucial to curbing pandemic – Nature

Related: WHO validates Sinovac-CoronaVac COVID-19 vaccine for emergency use and issues interim policy recommendations. AND Brazilian town experiment shows mass vaccination can wipe out COVID-19.

 


Study shows reduced neutralizing antibody activity induced by Pfizer–BioNTech vaccine against SARS-CoV-2 variants of concern B.1.617.2 (Delta) and B.1.351 (Beta).

6 Jun, 2021 | 23:59h | UTC

Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2  and B.1.351 (Beta) by BNT162b2 vaccination – The Lancet

Commentary: Pfizer-BioNTech vaccine recipients have lower antibody levels targeting the Delta variant – The Francis Crick Institute

 

Commentary on Twitter (thread – click for more)

 


Case report: Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT).

6 Jun, 2021 | 23:55h | UTC

Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT) – Journal of Thrombosis and Haemostasis

Commentary: COVID-19 vaccination: Thrombosis can be prevented by prompt treatment, researchers report – Medical University of Vienna

 


More data on the harmful effects of the COVID-19 pandemic on the mental health of adolescents.

6 Jun, 2021 | 23:52h | UTC

Depressive symptoms, mental wellbeing, and substance use among adolescents before and during the COVID-19 pandemic in Iceland: a longitudinal, population-based study – The Lancet Psychiatry

Commentaries: A lost generation? COVID-19 and adolescent mental health – The Lancet Psychiatry AND COVID-19 pandemic has had significant impact on the mental health of adolescents – Columbia University Mailman School of Public Health

 

Commentary on Twitter (thread – click for more)

https://twitter.com/TheLancetPsych/status/1400783180937011202

 


2 new meta-analysis detail neurologic and psychiatric conditions in COVID-19.

6 Jun, 2021 | 23:54h | UTC

Neurologic, psychiatric conditions common in COVID-19 – CIDRAP

Meta-analysis 1: Neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives – Journal of Neurology, Neurosurgery & Psychiatry

Meta-analysis 2: Central and peripheral nervous system involvement by COVID-19: a systematic review of the pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings – BMC Infectious Diseases

Related: Large study finds 1 in 3 Covid-19 survivors have subsequent mental health and neurological conditions

 


Perspective | Could statins do more than lower cholesterol in patients with COVID-19? – “Don’t Start, Don’t Stop”.

6 Jun, 2021 | 23:49h | UTC

Could Statins Do More Than Lower Cholesterol in Patients With COVID-19? – JAMA

 


Opinion | “Doctors have been blamed for the rise in black fungus in India, but the COVID treatment guidelines could be contributing” – improper use of antibiotics and higher than usual doses of corticosteroids may be contributing to the emergence of mucormycosis and other fungal co-infections.

6 Jun, 2021 | 23:48h | UTC

Doctors have been blamed for the rise in black fungus in India, but the COVID treatment guidelines could be contributing – The Conversation

See also: Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave? – The Lancet Respiratory Medicine

Related: The Emergence of COVID-19 Associated Mucormycosis: Analysis of Cases From 18 Countries – The Lancet AND What Is ‘Black Fungus’? And Why Is It Spreading Among India’s COVID Patients? – NPR AND Mucormycosis: The ‘black fungus’ maiming Covid patients in India AND What is mucormycosis, the fungal infection affecting COVID patients in India? – The Conversation

 


Investigation | Covid 19: How harm reduction advocates and the tobacco industry capitalized on the pandemic to promote nicotine.

6 Jun, 2021 | 23:51h | UTC

Covid 19: How harm reduction advocates and the tobacco industry capitalised on the pandemic to promote nicotine – The BMJ

Commentaries: Researchers report how the tobacco and e-cigarette industry capitalized on COVID-19 to promote smoking – News Medical AND Investigation discredits studies suggesting lower COVID-19 risk for smokers

 


Another study shows a high frequency of antibiotic use among patients hospitalized with Covid-19 (85.2%), despite low rates of confirmed secondary bacterial infections.

4 Jun, 2021 | 10:43h | UTC

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study – The Lancet Microbe

Commentaries: Very high use of antibiotics in COVID-19 treatment could be reduced – University of Glasgow AND More evidence of frequent antibiotic use noted in COVID patients – CIDRAP AND Covid-19: Antimicrobial use was high during first wave despite bacterial co-infections being rare, study finds – The BMJ

Related: Many hospitalized Covid-19 patients are given antibiotics. That’s a problem – STAT

 

Commentary on Twitter (thread – click for more)

 


In a Mendelian randomization study, researchers found no genetic evidence to support an association between Vitamin D levels and COVID-19 susceptibility, severity, or hospitalization.

4 Jun, 2021 | 10:35h | UTC

Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study – PLOS Medicine

Commentary: Vitamin D may not provide protection from COVID-19 susceptibility or disease severity, study suggests – PLOS

Related: Living systematic review: The evidence is insufficient to determine the benefits and harms of vitamin D supplementation as a treatment of COVID‐19. AND RCT: Vitamin D3 does not improve outcomes in hospitalized patients with moderate to severe COVID-19

 


RCT: Prophylactic post-exposure prophylaxis with Bamlanivimab reduced the incidence of Covid-19 among residents and staff of skilled nursing and assisted living facilities.

4 Jun, 2021 | 10:40h | UTC

Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial – JAMA

Editorial: Bamlanivimab for Prevention of COVID-19

 


[Preprint] Covid-19 B.1.617.2 variant of concern (Delta) is associated with increased transmissibility compared to B.1.1.7 (Alpha) that will rapidly lead to B.1.617.2 becoming the prevailing variant in the UK.

4 Jun, 2021 | 10:36h | UTC

Interim estimates of increased transmissibility, growth rate, and reproduction number of the Covid-19 B.1.617.2 variant of concern in the United Kingdom – medRxiv

Related: Covid: Indian variant ‘now dominant’ in the UK – BBC

 


United States Unveils Global Vaccine Sharing Scheme for 80 Million Doses by End June

4 Jun, 2021 | 10:32h | UTC

BREAKING – United States Unveils Global Vaccine Sharing Scheme for 80 Million Doses by End June – Health Policy Watch

See also: Statement by President Joe Biden on Global Vaccine Distribution – The White House

 


WHO: Vaccinating kids ‘not a high priority’ amid shortage

4 Jun, 2021 | 10:31h | UTC

WHO: Vaccinating kids ‘not a high priority’ amid shortage – Associated Press

Related: WHO: Wealthy nations urged to delay youth Covid vaccines, donate to solidarity scheme AND Editorial: Vaccinating children against SARS-CoV-2 – “Hard to justify right now for most children in most countries”. AND Opinion | American Kids Can Wait – “The U.S. should delay shots for children until global vaccine-manufacturing capacity significantly expands and the crisis in India subsides”. AND Vaccinating children before poor morally wrong, Oxford scientist says – BBC

 


Countries hit hardest by COVID-19 – estimated mortality countries will have on September 1, 2021.

3 Jun, 2021 | 11:09h | UTC

Countries Hit Hardest by COVID-19 – Think Global Health

 

Commentary on Twitter (thread – click for more)

 


Cohort study showed good recovery for most children 6 months after Pediatric Inflammatory Multisystem Syndrome (PIMS-TS) associated with SARS-CoV-2.

3 Jun, 2021 | 11:06h | UTC

6-month multidisciplinary follow-up and outcomes of patients with paediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary paediatric hospital: a retrospective cohort study – The Lancet Child & Adolescent Health

Commentary: Most severe effects of MIS-C in children typically resolve within six months, new research suggests – CNN AND Children who developed a rare inflammation disease after COVID-19 are mostly better after 6 months, but some still suffer fatigue and anxiety, a small UK study found – Insider AND Most severe effects of PIMS-TS resolved at six months – HealthDay

 

Commentary on Twitter

 


Tracking Coronavirus Vaccinations Around the World.

3 Jun, 2021 | 11:01h | UTC

Tracking Coronavirus Vaccinations Around the World – The New York Times

 


What We Know About the Dangerous COVID B.1.617.2 (Delta) Variant – “the Delta variant may soon become the most dominant COVID strain in the world and lead to rapid outbreaks in countries without high vaccination rates”.

3 Jun, 2021 | 11:05h | UTC

What We Know About the Dangerous COVID B.1.617.2 (Delta) Variant – Intelligencer

 

Commentary on Twitter

 


A pandemic upside: The flu virus became less diverse, simplifying the task of making flu shots.

3 Jun, 2021 | 10:57h | UTC

A pandemic upside: The flu virus became less diverse, simplifying the task of making flu shots – STAT

 


Brazilian town experiment shows mass vaccination can wipe out COVID-19.

3 Jun, 2021 | 10:59h | UTC

Brazilian town experiment shows mass vaccination can wipe out COVID-19 – Science (a few articles per month are free)

Related: [Press release – not published yet] The city of Serrana in Brazil has seen a 95% drop in Covid-19 deaths after almost all adults were vaccinated with Chinese CoronaVac – The findings suggest the pandemic can be controlled after 75% of people are fully vaccinated.

 


WHO: New US$50 billion health, trade and finance roadmap to end the pandemic and secure a global recovery.

2 Jun, 2021 | 08:44h | UTC

New US$50 billion health, trade and finance roadmap to end the pandemic and secure a global recovery – World Health Organization

Commentary: Global Leaders Call for $50-billion Investment to End COVID-19, boost economies – Health Policy Watch

 


Israel reports link between rare cases of heart inflammation and COVID-19 vaccination in young men.

2 Jun, 2021 | 08:37h | UTC

Israel reports link between rare cases of heart inflammation and COVID-19 vaccination in young men – Science (a few articles per month are free)

Related: CDC is investigating several reports that teenagers and young adults may have developed myocarditis after receiving mRNA vaccines. Most cases were mild, more often in males than females, more often following dose 2 than dose 1, and typically, within 4 days after vaccination.

 

Commentary on Twitter

https://twitter.com/rfsquared/status/1399803644288061442

 


WHO validates Sinovac-CoronaVac COVID-19 vaccine for emergency use and issues interim policy recommendations.

2 Jun, 2021 | 08:42h | UTC

WHO validates Sinovac COVID-19 vaccine for emergency use and issues interim policy recommendations – World Health Organization

Commentary: WHO grants emergency approval to 2nd Chinese COVID vaccine – MedicalXpress

 

Commentary on Twitter (thread – click for more)


After COVID-19 successes, researchers push to develop mRNA vaccines for other infectious diseases and cancer.

2 Jun, 2021 | 08:34h | UTC

After COVID-19 successes, researchers push to develop mRNA vaccines for other diseases – Nature Medicine

 


Review: SARS-CoV-2 variants, spike mutations and immune escape.

2 Jun, 2021 | 08:33h | UTC

SARS-CoV-2 variants, spike mutations and immune escape – Nature Reviews Microbiology

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.